442 related articles for article (PubMed ID: 25721086)
1. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
4. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
5. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
[TBL] [Abstract][Full Text] [Related]
6. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
[TBL] [Abstract][Full Text] [Related]
7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
8. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
10. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
11. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
Yamamoto T; Digumarthi H; Aranbayeva Z; Wataha J; Lewis J; Messer R; Qin H; Dickinson D; Osaki T; Schuster GS; Hsu S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):318-25. PubMed ID: 17196232
[TBL] [Abstract][Full Text] [Related]
12. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways.
Hung PF; Wu BT; Chen HC; Chen YH; Chen CL; Wu MH; Liu HC; Lee MJ; Kao YH
Am J Physiol Cell Physiol; 2005 May; 288(5):C1094-108. PubMed ID: 15647388
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J
Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and protein kinase B pathways.
Shih LJ; Chen TF; Lin CK; Liu HS; Kao YH
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C308-21. PubMed ID: 27147558
[TBL] [Abstract][Full Text] [Related]
16. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
Yoshimura H; Yoshida H; Matsuda S; Ryoke T; Ohta K; Ohmori M; Yamamoto S; Kiyoshima T; Kobayashi M; Sano K
Mol Med Rep; 2019 Aug; 20(2):1139-1148. PubMed ID: 31173211
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
20. Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells.
Hsu S; Farrey K; Wataha J; Lewis J; Borke J; Singh B; Qin H; Lapp C; Lapp D; Nguyen T; Schuster G
Anticancer Res; 2005; 25(1A):63-7. PubMed ID: 15816520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
